Greenwich LifeSciences
GLSI
51 hedge funds and large institutions have $11.2M invested in Greenwich LifeSciences in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
11% more funds holding
Funds holding: 46 → 51 (+5)
1% more capital invested
Capital invested by funds: $11.1M → $11.2M (+$87.9K)
0.38% more ownership
Funds ownership: 8.84% → 9.21% (+0.38%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$534K |
| 2 |
Millennium Management
New York
|
+$325K |
| 3 |
Goldman Sachs
New York
|
+$157K |
| 4 |
BlackRock
New York
|
+$143K |
| 5 |
Renaissance Technologies
New York
|
+$141K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Corebridge Financial
Houston,
Texas
|
-$28.5K |
| 2 |
Citigroup
New York
|
-$20.7K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$17.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.4K |
GLSI Hedge Fund Activity: Q2 2025 in Review
51 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2025, worth a combined $11.2M — up 0.79% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new GLSI positions and 3 closed out — a net gain of 6 holders — while 20 added to existing stakes and 10 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $534K. The largest seller was Corebridge Financial, exiting entirely with an estimated $28.5K sold.
- 51 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2025, up from 46 in Q1 2025.
- Funds reported $11.2M of Greenwich LifeSciences stock for Q2 2025, up 0.79% quarter-over-quarter.
- 9 funds opened new Greenwich LifeSciences positions in Q2 2025 and 3 closed out, a net change of +6 holders.
- The largest Greenwich LifeSciences buyer in Q2 2025 was Marshall Wace, an estimated $534K added.
- The largest Greenwich LifeSciences seller in Q2 2025 was Corebridge Financial, an estimated $28.5K sold.
Based on aggregated 13F filings for Q2 2025.